about
Gelsolin Amyloidogenesis Is Effectively Modulated by Curcumin and Emetine Conjugated PLGA Nanoparticles.Current perspectives on cardiac amyloidosis.IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.Identification of a novel TTR Gly67Glu mutant and the first case series of familial transthyretin amyloidosis in Hong Kong Chinese.Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Drug Insight: emerging therapies for amyloidosis.
@ast
Drug Insight: emerging therapies for amyloidosis.
@en
type
label
Drug Insight: emerging therapies for amyloidosis.
@ast
Drug Insight: emerging therapies for amyloidosis.
@en
prefLabel
Drug Insight: emerging therapies for amyloidosis.
@ast
Drug Insight: emerging therapies for amyloidosis.
@en
P2860
P356
P1476
Drug Insight: emerging therapies for amyloidosis.
@en
P2093
Julian D Gillmore
Philip N Hawkins
P2860
P304
P356
10.1038/NCPNEPH0169
P577
2006-05-01T00:00:00Z